Henlez
Latest round
- Seed
Last raised
- Oct 2022
Total raised
- $1M
Investors
- 2
About Henlez
Based in Denmark, and founded in 2019, Henlez ApS operates as a biotechnology company. The company was founded by its CEO Jeppe Mouritsen, and Gregor Jemec. Henlez develops and offers topical HEN-001, which is a precision enzyme-based treatment that utilizes enzymes to control skin problems including hidradenitis suppurativa.
Who invested in Henlez
2 investors across 1 round
See all investors in Henlez
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 24, 2022
Amount
$1M
Investors
Questions about Henlez
Who invested in Henlez?
Henlez has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Henlez raised?
Henlez has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Henlez last raise money?
Henlez's most recent round on record is a Seed, in Oct 2022.
What does Henlez do?
Based in Denmark, and founded in 2019, Henlez ApS operates as a biotechnology company.
Where is Henlez headquartered?
Henlez is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Henlez?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Henlez's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Henlez? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.